Brenntag Expands Biopharma Capabilities in EMEA with Acquisition of mcePharma

Brenntag acquires mcePharma to expand GMP capabilities in biopharma services - Pharmafile

Brenntag Specialties has acquired Czech-based mcePharma, strengthening its position in the pharma and biopharma industries through expanded continuous monitoring platform (CMP) capabilities and a more strategic presence in central Europe. The acquisition will enable Brenntag to develop a central hub for good manufacturing practice (GMP) value-added services across Europe, the Middle East and Africa (EMEA), […] The post Brenntag acquires mcePharm…

Brenntag Expands Biopharma Capabilities in EMEA with Acquisition of mcePharma

Brenntag Expands Biopharma Capabilities in EMEA with Acquisition of mcePharma (IN BRIEF) Brenntag has acquired mcePharma a.s. in the Czech Republic to expand its capabilities in the pharmaceutical and biopharmaceutical value chain across EMEA. This acquisition strengthens Brenntag’s GMP services, including biobuffers and liquid blending, to meet growing demand in the biopharma sector. With advanced GMP facilities and expertise in OTC product dev…

Brenntag Specialties acquires mcePharma

Brenntag, the global market leader in chemicals and ingredients distribution, has announced the acquisition of mcePharma, Czech Republic.The acquisition and additional investments in the site of mcePharma will strengthen Brenntag’s capabilities across the entire pharmaceutical and biopharmaceutical value chain.The existing state-of-the-art GMP facilities, advanced sampling services, and expertise in both OTC product development and GMP powder pa…